F. Stenback et al., P53 EXPRESSION IN SKIN CARCINOGENESIS AND RELATIONSHIPS TO CELL-PROLIFERATION AND TUMOR-GROWTH, European journal of cancer, 34(9), 1998, pp. 1415-1424
The immunoreactivity of p53 protein was studied in relation to tumour
development, histopathological characteristics, cell proliferation, an
d basement membrane organisation following the induction of skin carci
nogenesis in tumour-sensitive and -resistant mouse strains by ultravio
let (UV) irradiation or 7,12-dimethylbenz(a)anthracene (DMBA). In non-
neoplastic skin exposed to UV irradiation or DMBA, p53 immunoreactivit
y was observed in nearly 50% of the basal layer cells. These cells wer
e morphologically and histochemically indistinguishable from the p53-n
egative cells, occurring similarly in the tumour-producing and the tum
our-negative mouse strains and regardless of subsequent tumour formati
on. In induced epidermal hyperplasia and in benign tumours, p53-positi
ve and proliferating cells constituted 40-50% of all cells in the basa
l layer, while superficial cells were p53 negative. In dysplastic epid
ermis, p53-positive cells and proliferating cells were seen in all cel
l layers. In the case of squamous cell carcinomas, p53-positive prolif
erating cells in differentiated neoplasms were localised close to the
basement membrane and, more frequently, in border areas showing invasi
on and basement membrane destruction. In horn cysts, centrally located
cells were nonproliferating and p53 negative. In moderately different
iated neoplasms, proliferating cells were located closer to the baseme
nt membrane, while p53-positive cells were distributed diffusely in th
e neoplasm. In poorly differentiated neoplasms, p53-positive cells wer
e more common than proliferating cells and were arranged in a diffuse
pattern. The results showed that the number and location of p53-positi
ve cells depended upon histology, with a close relationship to tumour
type and degree of malignancy, but not on the mode of induction, nor o
n the animal strain or the relationship to subsequent tumour formation
. (C) 1998 Elsevier Science Ltd. All rights reserved.